Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 69, Issue 2, 2008, Pages 417-425

  Sun, Wei ^a   Mao, Shirui ^a   Mei, Dan ^a   Kissel, Thomas ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Chitosan; Enoxaparin; LMWH; Nanoparticle; PEGylation; Polyelectrolyte complexes; Thiolated chitosan; Trimethyl chitosan

Indexed keywords

CHITOSAN; ENOXAPARIN; NANOPARTICLE; POLYELECTROLYTE; POLYMER;

ANEMOMETRY; ARTICLE; ATOMIC FORCE MICROSCOPY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); DENSITY; DISSOCIATION; ELECTRICITY; IONIC STRENGTH; LIGHT SCATTERING; METHYLATION; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NANOENCAPSULATION; PARTICLE SIZE; PH; PHYSICAL CHEMISTRY; PKA; STRUCTURE ANALYSIS;

ANTICOAGULANTS; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; ELECTROCHEMISTRY; ENOXAPARIN; HYDROGEN-ION CONCENTRATION; LIGHT; MICROSCOPY, ATOMIC FORCE; MOLECULAR WEIGHT; NANOPARTICLES; PARTICLE SIZE; POLYMERS; SCATTERING, RADIATION; SOLUBILITY;

EID: 43249115310     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.01.016     Document Type: Article

References (32)

1. Hirsh J., Warkentin T., Raschke R., Granger C., Ohman E., and Dalen J. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 114 (1998) 489-510
2. Prasad Y., Minamimoto T., Yoshikawa Y., Shibata N., Mori S., Matsuura A., and Takada K. In situ intestinal absorption studies on low molecular weight heparin in rats using Labrasol as absorption enhancer. Int. J. Pharm. 271 (2004) 225-232
3. Ross B., and Toth I. Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. Curr. Drug Deliv. 2 (2005) 277-287
4. Schmitz T., Leitner V., and Bernkop-Schnürch A. Oral heparin delivery: design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system. J. Pharm. Sci. 94 (2005) 966-973
5. Kim S., Vaishali B., Lee E., Lee S., Lee Y., Kumar T., Moon H., and Byuna Y. Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation. Thromb. Res. 117 (2006) 419-427
6. Hoffart V., Lamprecht A., Maincent P., Lecompte T., Vigneron C., and Ubrich N. Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. J. Control. Release 113 (2006) 38-42
7. Mao S., Bakowsky U., Jintapattanakit A., and Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J. Pharm. Sci. 95 (2006) 1035-1048
8. Krauland A., and Alonso M. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm. 340 (2007) 134-142
9. Gaserod O., Jolliffe I.G., Hampson F.C., Dettmar P.W., and Skjak-Braek G. The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan. Int. J. Pharm. 175 (1998) 237-246
10. Illum L., Jabbal-Gill I., Hinchcliffe M., Fisher A.N., and Davis S.S. Chitosan as a novel nasal delivery system for vaccines. Adv. Drug Deliv. Rev. 51 (2001) 81-96
11. Hejazi R., and Amiji M. Chitosan-based gastrointestinal delivery systems. J. Control. Release 89 (2003) 151-165
12. Bernkop-Schnürch A. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems. Int. J. Pharm. 194 (2000) 1-13
13. Mao S., Shuai X., Unger F., Wittmar M., Xie X., and Kissel T. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymer. Biomaterials 26 (2005) 6343-6356
14. Mao S., Germershaus O., Fischer D., Linn T., Schnepf R., and Kissel T. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells. Pharm. Res. 22 (2005) 2058-2068
15. Bravo-Osuna I., Schmitz T., Bernkop-Schnürch A., Vauthier C., and Ponchel G. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int. J. Pharm. 316 (2006) 170-175
16. Kikuchi Y. Polyelectrolyte complex of heparin with chitosan. Makromol. Chem. 175 (1974) 2209-2211
17. Mao S., Shuai X., Unger F., Simon M., Bi D., and Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int. J. Pharm. 281 (2004) 45-54
18. Sieval A.B., Thanou M., Kotze A.F., Verhoef J.C., Brussee J., and Junginger H.E. Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohydr. Polym. 36 (1998) 157-165
19. Bernkop-Schnürch A., Hornof M., and Guggi D. Thiolated chitosans. Eur. J. Pharm. Biopharm. 57 (2004) 9-17
20. Jiao Y., Ubrich N., Marchand-Arvier M., Vigneron C., Hoffman M., Lecompte T., and Maincent P. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation 105 (2002) 230-235
21. Bravo-Osuna I., Ponchel G., and Vauthier C. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles. Eur. J. Pharm. Sci. 30 (2007) 143-154
22. Bernkop-Schnürch A. Thiomers: a new generation of mucoadhesive polymers. Adv. Drug Deliv. Rev. 57 (2005) 1569-1582
23. van der Merwe S.M., Verhoef J.C., Verheijden J.H.M., Kotze A.F., and Junginger H.E. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur. J. Pharm. Biopharm. 58 (2004) 225-235
24. Chen F., Zhang Z., Yuan F., Qin X., Wang M., and Huang Y. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery. Int. J. Pharm. 349 (2008) 226-233
25. Hamman J.H., Schultz C.M., and Kotze A.F. N-Trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev. Ind. Pharm. 29 (2003) 161-172
26. Kim T., Jiang H., Jere D., Park I., Cho M., Nah J., Choi Y., Akaike T., and Cho C. Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog. Polym. Sci. 32 (2007) 726-753
27. Serra L., Domenech J., and Peppas N.A. Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. Eur. J. Pharm. Biopharm. 63 (2006) 11-18
28. Park J.M., Muhoberac B.B., Dubin P.L., and Xia J. Effects of protein charge heterogeneity in protein-polyelectrolyte complexation. Macromolecules 25 (1992) 290-295
29. Sato T., Ishii T., and Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22 (2001) 2075-2080
30. Berger J., Reist M., Mayer J.M., Felt O., and Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur. J. Pharm. Biopharm. 57 (2004) 35-52
31. a of glucuronic acid and the carboxy groups of heparin by carbon-13 nuclear magnetic resonance spectroscopy. Biochem. J. 278 (1991) 689-695
32. Quintanar-Guerrero D., Allemann E., Fessi H., and Doelker E. Applications of the ion-pair concept to hydrophilic substances with special emphasis on peptides. Pharm. Res. 14 (1997) 119-127